
Ilia I. Ouspenski
Examiner (ID: 1237)
| Most Active Art Unit | 1644 |
| Art Unit(s) | 1644 |
| Total Applications | 1566 |
| Issued Applications | 1023 |
| Pending Applications | 156 |
| Abandoned Applications | 432 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 7061059
[patent_doc_number] => 20050003420
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-01-06
[patent_title] => 'Recycled mutagenesis of restriction endonuclease toward enhanced catalytic activity'
[patent_app_type] => utility
[patent_app_number] => 10/874527
[patent_app_country] => US
[patent_app_date] => 2004-06-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 9551
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0003/20050003420.pdf
[firstpage_image] =>[orig_patent_app_number] => 10874527
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/874527 | Recycled mutagenesis of restriction endonuclease toward enhanced catalytic activity | Jun 22, 2004 | Abandoned |
Array
(
[id] => 7192994
[patent_doc_number] => 20050163772
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-07-28
[patent_title] => 'B7S1: an immune modulator'
[patent_app_type] => utility
[patent_app_number] => 10/871696
[patent_app_country] => US
[patent_app_date] => 2004-06-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 21706
[patent_no_of_claims] => 54
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0163/20050163772.pdf
[firstpage_image] =>[orig_patent_app_number] => 10871696
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/871696 | B7S1: an immune modulator | Jun 15, 2004 | Abandoned |
Array
(
[id] => 348666
[patent_doc_number] => 07494779
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-02-24
[patent_title] => 'Method for producing human antibodies to human CD152 with properties of agonist, antagonist, or inverse agonist'
[patent_app_type] => utility
[patent_app_number] => 10/866120
[patent_app_country] => US
[patent_app_date] => 2004-06-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 6045
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 282
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/494/07494779.pdf
[firstpage_image] =>[orig_patent_app_number] => 10866120
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/866120 | Method for producing human antibodies to human CD152 with properties of agonist, antagonist, or inverse agonist | Jun 13, 2004 | Issued |
Array
(
[id] => 562255
[patent_doc_number] => 07465446
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-12-16
[patent_title] => 'Surrogate therapeutic endpoint for anti-CTLA4-based immunotherapy of disease'
[patent_app_type] => utility
[patent_app_number] => 10/857749
[patent_app_country] => US
[patent_app_date] => 2004-05-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11850
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/465/07465446.pdf
[firstpage_image] =>[orig_patent_app_number] => 10857749
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/857749 | Surrogate therapeutic endpoint for anti-CTLA4-based immunotherapy of disease | May 26, 2004 | Issued |
Array
(
[id] => 195512
[patent_doc_number] => 07635472
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-12-22
[patent_title] => 'Pharmaceutical compositions comprising bispecific anti-cd3, anti-cd19 antibody constructs for the treatment of b-cell related disorders'
[patent_app_type] => utility
[patent_app_number] => 10/554852
[patent_app_country] => US
[patent_app_date] => 2004-05-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 17
[patent_no_of_words] => 15809
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 71
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/635/07635472.pdf
[firstpage_image] =>[orig_patent_app_number] => 10554852
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/554852 | Pharmaceutical compositions comprising bispecific anti-cd3, anti-cd19 antibody constructs for the treatment of b-cell related disorders | May 25, 2004 | Issued |
Array
(
[id] => 7082689
[patent_doc_number] => 20050048069
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-03-03
[patent_title] => 'Methods and compositions for modulating immunity'
[patent_app_type] => utility
[patent_app_number] => 10/850562
[patent_app_country] => US
[patent_app_date] => 2004-05-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 41
[patent_figures_cnt] => 41
[patent_no_of_words] => 46143
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0048/20050048069.pdf
[firstpage_image] =>[orig_patent_app_number] => 10850562
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/850562 | Methods of treating allergy by administering a CD200 protein | May 20, 2004 | Issued |
Array
(
[id] => 7060575
[patent_doc_number] => 20050002935
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-01-06
[patent_title] => 'Use of B7-H3 as an immunoregulatory agent'
[patent_app_type] => utility
[patent_app_number] => 10/824481
[patent_app_country] => US
[patent_app_date] => 2004-04-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 16466
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0002/20050002935.pdf
[firstpage_image] =>[orig_patent_app_number] => 10824481
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/824481 | Use of B7-H3 as an immunoregulatory agent | Apr 14, 2004 | Abandoned |
Array
(
[id] => 7677670
[patent_doc_number] => 20040152156
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-08-05
[patent_title] => 'Regulation of human b7-h2 protein'
[patent_app_type] => new
[patent_app_number] => 10/250533
[patent_app_country] => US
[patent_app_date] => 2004-04-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 21821
[patent_no_of_claims] => 51
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0152/20040152156.pdf
[firstpage_image] =>[orig_patent_app_number] => 10250533
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/250533 | Regulation of human b7-h2 protein | Apr 8, 2004 | Abandoned |
Array
(
[id] => 5254165
[patent_doc_number] => 20070135621
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-06-14
[patent_title] => 'Therapeutic products with enhance ability to immunomodulate cell functions'
[patent_app_type] => utility
[patent_app_number] => 10/551819
[patent_app_country] => US
[patent_app_date] => 2004-04-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 11878
[patent_no_of_claims] => 55
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0135/20070135621.pdf
[firstpage_image] =>[orig_patent_app_number] => 10551819
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/551819 | Preparation of human, humanized or chimaeric antibodies or polypeptides having different binding profiles to Fcgamma receptors | Apr 4, 2004 | Issued |
Array
(
[id] => 7428478
[patent_doc_number] => 20040161814
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-08-19
[patent_title] => 'Kinase Capable of site-specific phosphorylation of IkappaBalpha'
[patent_app_type] => new
[patent_app_number] => 10/810793
[patent_app_country] => US
[patent_app_date] => 2004-03-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 32
[patent_figures_cnt] => 32
[patent_no_of_words] => 36582
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0161/20040161814.pdf
[firstpage_image] =>[orig_patent_app_number] => 10810793
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/810793 | Antibody to a kinase capable of site-specific phosphorylation of IκBα | Mar 25, 2004 | Issued |
Array
(
[id] => 7060556
[patent_doc_number] => 20050002916
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-01-06
[patent_title] => 'Cytokine-expressing cellular vaccine combinations'
[patent_app_type] => utility
[patent_app_number] => 10/807449
[patent_app_country] => US
[patent_app_date] => 2004-03-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 25
[patent_no_of_words] => 23048
[patent_no_of_claims] => 43
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0002/20050002916.pdf
[firstpage_image] =>[orig_patent_app_number] => 10807449
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/807449 | Cytokine-expressing cellular vaccine combinations | Mar 23, 2004 | Abandoned |
Array
(
[id] => 7264671
[patent_doc_number] => 20040151669
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-08-05
[patent_title] => 'Cell surface molecule mediating cell adhesion and signal transmission'
[patent_app_type] => new
[patent_app_number] => 10/798195
[patent_app_country] => US
[patent_app_date] => 2004-03-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 31659
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 67
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0151/20040151669.pdf
[firstpage_image] =>[orig_patent_app_number] => 10798195
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/798195 | Cell surface molecule mediating cell adhesion and signal transmission | Mar 10, 2004 | Abandoned |
Array
(
[id] => 7287059
[patent_doc_number] => 20040146991
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-07-29
[patent_title] => 'Human monoclonal antibody against a costimulatory signal transduction molecule AILIM and pharmaceutical use thereof'
[patent_app_type] => new
[patent_app_number] => 10/800250
[patent_app_country] => US
[patent_app_date] => 2004-03-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 78
[patent_figures_cnt] => 78
[patent_no_of_words] => 49031
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 99
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0146/20040146991.pdf
[firstpage_image] =>[orig_patent_app_number] => 10800250
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/800250 | Human monoclonal antibody against a costimulatory signal transduction molecule AILIM and pharmaceutical use thereof | Mar 9, 2004 | Abandoned |
Array
(
[id] => 7169910
[patent_doc_number] => 20050202522
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-09-15
[patent_title] => 'Method of screening for antimicrobial agents'
[patent_app_type] => utility
[patent_app_number] => 10/793746
[patent_app_country] => US
[patent_app_date] => 2004-03-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 58896
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0202/20050202522.pdf
[firstpage_image] =>[orig_patent_app_number] => 10793746
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/793746 | Method of screening for antimicrobial agents | Mar 7, 2004 | Abandoned |
Array
(
[id] => 439471
[patent_doc_number] => 07259147
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-08-21
[patent_title] => 'Methods of treating multiple sclerosis with a JTT-1 polypeptide'
[patent_app_type] => utility
[patent_app_number] => 10/794344
[patent_app_country] => US
[patent_app_date] => 2004-03-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 39
[patent_no_of_words] => 31472
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 117
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/259/07259147.pdf
[firstpage_image] =>[orig_patent_app_number] => 10794344
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/794344 | Methods of treating multiple sclerosis with a JTT-1 polypeptide | Mar 4, 2004 | Issued |
Array
(
[id] => 7326879
[patent_doc_number] => 20040253229
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-12-16
[patent_title] => 'Graft rejection suppressors'
[patent_app_type] => new
[patent_app_number] => 10/793171
[patent_app_country] => US
[patent_app_date] => 2004-03-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 14074
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0253/20040253229.pdf
[firstpage_image] =>[orig_patent_app_number] => 10793171
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/793171 | Methods of suppressing, treating, or preventing graft rejection with an antibody or a portion thereof that binds to AILIM | Mar 3, 2004 | Issued |
Array
(
[id] => 7319174
[patent_doc_number] => 20040224962
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-11-11
[patent_title] => 'Pharmaceutical composition for the treatment of obesity or to facilitate or promote weight loss'
[patent_app_type] => new
[patent_app_number] => 10/791984
[patent_app_country] => US
[patent_app_date] => 2004-03-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15338
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 76
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0224/20040224962.pdf
[firstpage_image] =>[orig_patent_app_number] => 10791984
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/791984 | Pharmaceutical composition for the treatment of obesity or to facilitate or promote weight loss | Mar 2, 2004 | Abandoned |
Array
(
[id] => 7234321
[patent_doc_number] => 20040157296
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-08-12
[patent_title] => 'Canine and feline B7-2 proteins, compositions and uses thereof'
[patent_app_type] => new
[patent_app_number] => 10/790396
[patent_app_country] => US
[patent_app_date] => 2004-03-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29894
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 22
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0157/20040157296.pdf
[firstpage_image] =>[orig_patent_app_number] => 10790396
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/790396 | Canine and feline B7-2 proteins, compositions and uses thereof | Feb 29, 2004 | Issued |
Array
(
[id] => 252803
[patent_doc_number] => 07579437
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-08-25
[patent_title] => 'Polypeptides and methods for making the same'
[patent_app_type] => utility
[patent_app_number] => 10/547364
[patent_app_country] => US
[patent_app_date] => 2004-02-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5187
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 4
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/579/07579437.pdf
[firstpage_image] =>[orig_patent_app_number] => 10547364
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/547364 | Polypeptides and methods for making the same | Feb 26, 2004 | Issued |
Array
(
[id] => 5022196
[patent_doc_number] => 20070148162
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-06-28
[patent_title] => 'Molecule which binds cd80 and cd86'
[patent_app_type] => utility
[patent_app_number] => 10/546727
[patent_app_country] => US
[patent_app_date] => 2004-02-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 7621
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0148/20070148162.pdf
[firstpage_image] =>[orig_patent_app_number] => 10546727
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/546727 | Molecule which binds cd80 and cd86 | Feb 25, 2004 | Abandoned |